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Article Summary 
Intense insecticide resistance is compromising malaria vector control in Côte d’Ivoire, driven 
principally by metabolic resistance mechanisms. Study findings support the urgent deployment of 
interventions incorporating newly approved insecticides and synergists to interrupt malaria 
transmission by insecticide-resistant vector populations. 
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Abstract  
 
Background 
Resistance to major public health insecticides in Côte d’Ivoire has intensified and now threatens the 
long-term effectiveness of malaria vector control interventions.  
 
Methods 
This study evaluated the bioefficacy of conventional and next-generation long-lasting insecticidal 
nets (LLINs), determined resistance profiles, and characterized molecular and metabolic mechanisms 
in wild Anopheles coluzzii from South-East Côte d’Ivoire in 2019. 
 
Results 
Phenotypic resistance was intense: more than 25% of mosquitoes survived exposure to ten times 
the doses of pyrethroids required to kill susceptible populations. Similarly, 24-hour mortality to 
deltamethrin-only LLINs was very low and not significantly different to an untreated net. Sub-lethal 
pyrethroid exposure did not induce significant delayed vector mortality 72 hours later. In contrast, 
LLINs containing the synergist piperonyl butoxide (PBO), or new insecticides, clothianidin and 
chlorfenapyr, were highly toxic to An. coluzzii. Pyrethroid-susceptible An. coluzzii were significantly 
more likely to be infected with malaria, compared to those that survived insecticidal exposure. 
Pyrethroid resistance was associated with significant over-expression of CYP6P4, CPY6Z1 and 
CYP6P3. 
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Conclusions 
Study findings raise concerns regarding the operational failure of standard LLINs and support the 
urgent deployment of vector control interventions incorporating PBO, chlorfenapyr or clothianidin in 
areas of high resistance intensity in Côte d'Ivoire. 
 
Keywords Anopheles coluzzii, insecticide resistance, Plasmodium falciparum, long-lasting insecticidal 
nets, Côte d’Ivoire, PBO, chlorfenapyr, clothianidin, CYP6P4, CYP6P3, CYP6Z1   
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Introduction  
 
In Côte d’Ivoire, malaria is a serious public health problem with the entire population of ~26.2 
million people at risk, and disease prevalence reaching as high as 63% in the south-west region [1]. 
Control of Anopheles gambiae s.l., the major malaria vector species group, has been through the 
efforts of the National Malaria Control Programme (NMCP), which has distributed insecticide-
treated nets (ITNs) as the primary vector control intervention. Indoor residual spraying (IRS) and 
larviciding in high transmission areas have been recommended as complementary strategies; 
implementation of the former has commenced in late 2020 [2]. Estimates of net coverage across the 
country remain low, with the proportion of households with at least one ITN per two persons rising 
from 31% in 2012 to 47% in 2016, and ITN use stagnating at 40% of households reporting sleeping 
under a net the previous night in both survey years [2]. The most recent universal net campaigns in 
Côte d’Ivoire in 2017–2018 issued conventional, pyrethroid (deltamethrin) long-lasting insecticidal 
nets (LLINs), aiming to achieve 90% coverage and 80% use [2]. However, country-wide, multi-class 
insecticide resistance among populations of An. gambiae s.l. is a growing cause for concern because 
of potential operational failure of current vector control strategies, both locally, as well as across the 
sub-Saharan region [2,3]. 
Resistance to pyrethroid and carbamate insecticides in Anopheles mosquitoes was first reported 
from the central region of Côte d’Ivoire in the early 1990s *4-7]. Local resistance to the major 
insecticide classes recommended by the World Health Organization (WHO) for adult mosquito 
control – pyrethroids, carbamates, organophosphates, and organochlorines – evolved rapidly [8–10] 
and has been increasing in intensity, driven largely by selective pressures imposed by 
contemporaneous scale-up of public health vector control interventions (including those targeting 
malaria, trypanosomiasis and onchocerciasis vectors) and use of agricultural pesticides [7, 11–14]. 
This escalation in resistance has now begun to compromise the insecticidal efficacy and community-
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wide impact of conventional, pyrethroid LLINs in Côte d’Ivoire *14,15+, although some levels of 
personal protection may still remain [15–17]. 
Amongst vector populations across Côte d’Ivoire, the L1014F kdr mutation is pervasive and has been 
implicated in some longitudinal trends in decreasing DDT and pyrethroid susceptibility [7, 11]; 
L1014S kdr and N1575Y resistance mutations have also been detected but at much lower 
frequencies [18]. Extreme carbamate (bendiocarb) resistance and pyrethroid cross-resistance in 
some An. gambiae s.s. populations are mediated by over-expression of CYP6P3 and CYP6M2 and 
duplication of the G119S Ace-1 mutation [19]. 
To support and safeguard future malaria control efforts in Côte d’Ivoire, this study evaluated the 
efficacy of conventional and next-generation LLINs for prospective distribution; determined current 
insecticide resistance profiles of An. gambiae s.l. (principally An. coluzzii); and characterized 
underlying molecular and metabolic resistance mechanisms.  
 
Methods 
Study area and mosquito collections 
The study protocol was approved by the Comité National d’Ethique des Sciences de la Vie et de la 
Santé (#069-19/MSHP/CNESVS-kp) and the London School of Hygiene and Tropical Medicine 
(#16782 and #16899). Study activities were conducted in the village of Aboudé, rural Agboville, 
Agnéby-Tiassa region, south-east Côte d'Ivoire (5°55’N, 4°13’W), selected due to its high mosquito 
densities and malaria prevalence [1]. Adult mosquitoes were collected using human landing catches 
(HLCs), inside and outside households from 18:00 to 06:00hr, for a total of 190 person/trap/nights 
between 5th July and 26th July, 2019. Unfed mosquitoes, morphologically identified as An. gambiae 
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s.l. [20], were tested in bioassays that same day, following a brief recovery period; blood-fed 
mosquitoes were first held for 2–3 days to allow for blood-meal digestion. 
  
WHO cone bioassay testing 
 
Two types of LLIN were evaluated in this study. PermaNet® 2.0 is a conventional LLIN treated with 
deltamethrin only (1.4g/kg±25%) and PermaNet® 3.0 is a PBO synergist LLIN, consisting of a roof 
containing PBO (25g/kg) and deltamethrin (4g/kg±25%) and side panels containing deltamethrin only 
(2.8g/kg±25%). WHO cone bioassays were used to test the susceptibility of An. gambiae s.l. exposed 
to unwashed PermaNet® 2.0, PermaNet® 3.0 roof panels and PermaNet® 3.0 side panels [21]. To 
control for potential variation in insecticide/synergist content, each of five LLINs per type was cut 
into 19 pieces, measuring 30 x 30cm, with each piece tested a maximum of three times.  
 
Resistance intensity and synergist bioassay testing 
 
Centers for Disease Control and Prevention (CDC) resistance intensity bioassays were performed for 
six public health insecticides (pyrethroids: alpha-cypermethrin, deltamethrin and permethrin; 
carbamate: bendiocarb; neonicotinoid: clothianidin; and pyrrole; chlorfenapyr) [22,23]. The 
diagnostic doses of all insecticides were evaluated (including clothianidin: 90µg/bottle [23] and 
chlorfenapyr: 100µg/bottle) and 2, 5 and 10 times the diagnostic dose of pyrethroid insecticides 
were also used. Per test, knock-down was recorded at 15-minute intervals for 30 minutes 
(pyrethroids and bendiocarb) or 60 minutes (clothianidin and chlorfenapyr) of insecticide exposure. 
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One-hour PBO pre-exposures were performed using WHO tube assays [24], prior to deltamethrin 
CDC bottle bioassay testing [22].  
 
WHO cone and CDC resistance intensity bioassay data were interpreted according to the WHO 
criteria [21,22].  Mosquitoes which died following exposure to a LLIN or 1X insecticide dose were 
stored at -20°C in RNAlater® (Thermo Fisher Scientific, UK) and were considered ‘susceptible’ for 
genotypic analysis. Surviving mosquitoes were held and scored for mortality after 24, 48 and 72 
hours to observe delayed mortality. Kaplan-Meier curves were used to visualize survival data, and 
Cox regression was used to compare post-exposure survival. Immediate mortality following LLIN (60 
minutes and 24 hours) or insecticidal exposure (30 or 60 minutes, depending on insecticide) were 
excluded. Surviving mosquitoes at 72 hours were stored at -20°C in RNAlater® and were considered 
‘resistant’ for genotypic analysis.  
 
Mosquito processing, identification of Anopheles gambiae s.l. species complex members and 
Plasmodium falciparum detection 
 
A sub-sample of field-caught mosquitoes tested in bioassays were selected for molecular analysis 
(n=912). Approximately equal numbers of specimens were chosen to represent phenotypically 
‘susceptible’ or ‘resistant’ mosquitoes for each LLIN type or insecticide dose, selected across 
different replicates/testing days to capture as much population-level variation as possible. RNA was 
extracted from individual whole-body mosquitoes according to standard protocols [23]. Field An. 
gambiae s.l. were identified to species-level [25] and were screened for the presence of Plasmodium 
falciparum [26]. 
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Characterization of insecticide resistance mechanisms: target site mutations  
The same cohort of field mosquitoes (n=912) were tested for the presence of L1014F kdr [27] and 
N1575Y mutations [28]. A sub-sample of mosquitoes (n=49) which were exposed to bendiocarb, 
clothianidin or chlorfenapyr were tested for the presence of the G119S Ace-1 mutation [29]. 
Pearson’s Chi-squared tests and Fisher’s exact tests (when sample sizes were small) were used to 
investigate the statistical association between resistance status, allele frequencies and deviations 
from Hardy-Weinberg equilibrium. 
 
Characterization of insecticide resistance mechanisms: metabolic gene expression 
 
Relative expression of five metabolic genes (CYP6P3, CYP6P4, CYP6Z1 CYP6P1 and GSTE2) was 
measured in all field collected mosquitoes (n=912), using multiplex quantitative real-time PCR (qRT-
PCR) assays, relative to the housekeeping gene ribosomal protein S7 (RPS7) [30]. In addition, gene 
expression levels were measured in susceptible An. coluzzii N’gousso colony mosquitoes (n=48). All 
samples were run in technical triplicate. Expression level and Fold Change (FC) of each target gene 
between resistant and susceptible field samples, relative to the susceptible laboratory strain, were 
calculated using the 2-ΔΔCT method incorporating PCR efficiency, normalised relative to the 
endogenous control gene (RPS7). 
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Results 
Mosquito collections and species identification 
 
A total of 4,609 female An. gambiae s.l. mosquitoes were collected in Agboville, Côte d'Ivoire. Of 
those, 912, which were previously tested in either LLIN bioefficacy assays (n=384) or resistance 
intensity bioassays (n=528), were selected for molecular species identification, with 805 (88.3%) 
determined to be An. coluzzii, 75 (8.2%), An. gambiae s.s. and 22 (2.4%) An. gambiae-An. coluzzii 
hybrids; 10 individuals did not amplify.  
 
Long-lasting insecticidal net efficacy 
 
A total of 2,666 field-caught An. gambiae s.l. were used to assess the bioefficacy of conventional 
pyrethroid-treated LLINs (PermaNet® 2.0 and PermaNet® 3.0 side panels) and next-generation 
synergist LLINs (PermaNet® 3.0 roof panels), compared to an untreated control (Figure 1).  
 
Overall, levels of An. gambiae s.l. knock-down and mortality to deltamethrin LLINs, were very low 
and largely equivalent to the untreated control net (Figure 1). At 60 minutes, average mosquito 
knock-down to the untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels was 1.56% (95% 
CI: 1.13-1.99%), 0.54% (95% CI: 0.42-0.65%) and 1.75% (95% CI: 1.49-2.0%), respectively. By contrast, 
average mosquito knock-down for PBO-containing PermaNet® 3.0 roof panels was significantly 
higher (79.8%, 95% CI: 79.07-80.48%; 𝝌2 =705.51, 968.65 and 937.33; p<0.001, versus untreated 
control, PermaNet® 2.0 and PermaNet® 3.0 side panels, respectively) (Figure 1).  
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At 24 hours, mortality to the untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels 
remained low (6.11%, 95% CI: 4.71-7.51%; 5.44%, 95% CI: 4.58-6.29% and 3.66%, 95% CI: 3.12-
4.19%, respectively), while mortality to PermaNet® 3.0 roof panels increased only marginally but still 
remained significantly higher (83.81%, 95% CI: 83.15-84.47%; 𝝌2 =727.96, 914.61 and 963.09; 
p<0.001 for all, versus untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels, 
respectively) (Figure 1). PermaNet® 3.0 roof panels reached minimal effectiveness (knock-down 
≥75%) 60 minutes after exposure and optimal effectiveness (mortality ≥80%) at 24 hours. Neither of 
the deltamethrin-only LLINs reached either effectiveness threshold at any time point.  
 
Insecticide resistance intensity 
 
One thousand, nine hundred and forty-three field-caught An. gambiae s.l. were tested in resistance 
bioassays. Intense pyrethroid resistance was evident with more than 25% of mosquitoes surviving 
exposure to ten times the dose of insecticide required to kill a susceptible population (Figure 2A). At 
the diagnostic dose, mosquito mortality did not exceed 25% for any pyrethroid tested, which was 
consistent with the high survival rates observed during cone bioassays using conventional LLINs 
(Figure 1). In general, levels of resistance to alpha-cypermethrin, deltamethrin and permethrin were 
not significantly different at each insecticide concentration tested (Figure 2A).  
 
By comparison, carbamate tolerance was low, with mean knock-down of 94.53% (95% CI: 92.11-
96.95%) after 30 minutes exposure to the diagnostic dose of bendiocarb. Similarly, high levels of 
susceptibility to new insecticides clothianidin and chlorfenapyr were observed, with mean mortality 
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of 94.11% (95% CI: 93.43-94.80%; n=102) and 95.54% (95% CI: 94.71-96.36%; n=112), respectively, 
72 hours after exposure to the tentative diagnostic doses.  
 
Pre-exposure to PBO increased average An. gambiae s.l. mortality significantly from 14.56% (95% CI: 
6.24-22.88%) to 72.73% (95% CI: 64.81-79.43) and from 44.66% (95% CI: 34.86-54.46%) to 94.17% 
(95% CI: 91.12-97.22) after exposure to one or two times the diagnostic dose of deltamethrin (Figure 
2B). 
 
Mosquito survival following insecticidal exposure 
 
All An. gambiae s.l. tested in LLIN bioefficacy or resistance intensity bioassays, were held for 72 
hours, to assess any impact of insecticide or net exposure on delayed mortality. For LLIN bioassays, 
there was little evidence for any reduction in survival during this holding period (Cox regression 
P=0.149, 0.272 and 0.85 comparing PermaNet® 2.0, PermaNet® 3.0 side panels and PermaNet® 3.0 
roof panels versus untreated control, respectively) (Table 1 and Figure 3A). Exposure to the 
diagnostic doses of all insecticides in CDC bottle bioassays did not induce significant delayed 
mortality over 72 hours (Cox regression P>0.05 for all insecticides compared to the control; with the 
exception of chlorfenapyr, P=0.02) (Table 1 and Figure 3B). This phenomenon was also observed at 
increasing pyrethroid doses (Cox regression P>0.05 for alpha-cypermethrin, deltamethrin and 
permethrin 5X and 10X versus either the control or diagnostic dose) (Table 1; Figure 3C and 3D).  
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Malaria prevalence 
 
Of the 912 An. gambiae s.l. mosquitoes assayed, 31 tested positive for P. falciparum (3.4%). For PCR-
confirmed An. coluzzii, P. falciparum prevalence was 3.50% (28/805); the remaining three infections 
were in An. gambiae s.s. (4%; 3/75). By resistance phenotype, susceptible An. coluzzii (i.e. those 
which died following pyrethroid exposure) were more likely to be infected with malaria, compared 
to resistant mosquitoes (�2 =4.6987; p=0.030); infection rates were 5.94% (13/219) and 2.49% 
(10/401), respectively. 
 
Target site resistance mutations 
 
L1014F kdr screening revealed 92.2% (796/863) of An. gambiae s.l. mosquitoes harboured the 
mutation; 71.5% (617/863) were homozygous, 20.7% (179/863) were heterozygous, 5.1% (44/863) 
were wild type and 2.6% (23/863) did not amplify. For PCR-confirmed An. coluzzii, L1014F kdr 
prevalence was 87.8% (707/805); 66.6% (536/805) were homozygous for the mutation, 21.2% 
(171/805) were heterozygous, 5.3% (43/805) were wild type and 2.2% (18/805) did not amplify. For 
An. coluzzii, population-level L1014F kdr allele frequency was 0.83, with evidence for significant 
deviations from Hardy-Weinberg equilibrium (�2 =29.124; p<0.0001). There was no significant 
association between L1014F kdr frequency and ability of An. coluzzii,  to survive pyrethroid 
exposure, in either LLIN or resistance bioassays (�2 =2.0001; p=0.157 and �2 =3.6998; p=0.054, 
respectively). Similarly, there was no significant association between L1014F kdr and ability of An. 
coluzzii, to survive PBO pre-exposure and pyrethroid treatment, in either LLIN or resistance 
bioassays (�2 =0.0086; p=0.926, Fisher’s exact=0.429, respectively). For PCR-confirmed An. gambiae 
s.s., L1014F kdr prevalence was 95.3% (61/64); 89.1% (57/64) were homozygous for the mutation, 
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6.3% (4/64) were heterozygous, none were wild type and 4.7% (3/64) did not amplify. There was no 
significant association between L1014F kdr frequency and ability of An. gambiae s.s. to survive 
pyrethroid or PBO pre-exposure and pyrethroid treatment (in either LLIN or resistance bioassays) as 
all tested individuals harboured this mutation (n=61). For An. gambiae s.s., population-level L1014F 
kdr allele frequency was 0.97, with no significant deviations from Hardy-Weinberg equilibrium (�2 
=0.070; p=0.791). 
 
N1575Y screening revealed 2.3% (21/912) of An. gambiae s.l. mosquitoes harboured the mutation; 
all were heterozygotes. N1575Y prevalence was 1.1% (9/805) and 16% (12/75) for PCR-confirmed 
An. coluzzii and An. gambiae s.s., respectively; 0.99% (9/912) did not amplify. There was no evidence 
for ongoing N1575Y selection in either species (�2 =0.026; p=0.873 and �2 =0.62; p=0.433 for An. 
coluzzii and An. gambiae s.s., respectively). For An. coluzzii, there was no significant association 
between N1575Y frequency and ability of mosquitoes to survive pyrethroid exposure, in LLIN or 
resistance bioassays (�2 =0.0001; p=0.993 and �2 =0.3244; p=0.569, respectively).  
 
G119S Ace-1 screening revealed 55.1% (27/49) of An. gambiae s.l. mosquitoes harboured the 
mutation; all were heterozygotes. G119S Ace-1 prevalence was 64.9% (24/37) and 27.3% (3/11) for 
PCR-confirmed An. coluzzii and An. gambiae s.s., respectively; one remaining An. gambiae-An. 
coluzzii hybrid was wild type. For An. coluzzii, population-level G119S Ace-1 allele frequency was 
0.32, with evidence for significant deviations from Hardy-Weinberg equilibrium (�2 =8.525; 
p=0.00350). For An. gambiae s.s., population-level G119S Ace-1 allele frequency was 0.14, with no 
significant deviations from Hardy-Weinberg equilibrium (�2 =0.274; p=0.6005). For An. coluzzii, there 
was a significant association between G119S Ace-1 frequency and surviving bendiocarb exposure 
(Fisher’s exact test = 0.005).  
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Metabolic resistance mechanisms 
 
Comparison of metabolic gene expression levels in field populations of An. coluzzii and An. gambiae 
s.s. demonstrated significant upregulation of CYP6P4 (FC=5.88, 95% CI: 5.19-44.06; and 6.08, 95% CI: 
5.43-50.64), CPY6Z1 (FC=4.04, 95% CI: 3.69-41.54; and 3.56, 95% CI: 3.24-36.25) and CYP6P3 
(FC=12.56, 95% CI: 11.40-123.83; and 13.85, 95% CI: 12.53-132.03), relative to a susceptible 
laboratory colony, respectively (Figure 4). More modest overexpression of CYP6P1 and GSTE2 was 
observed (FC=1.18, 95% CI: 1.08-12.31; and 1.28, 95% CI: 1.17-14.40; FC=0.56, 95% CI: 0.48-3.32; 
and 0.67, 95% CI: 0.58-4.29; for An. coluzzii and An. gambiae s.s., respectively) (Figure 4). Levels of 
FC did not differ significantly between the two species for any gene nor by malaria infection status in 
wild An. coluzzii. 
 
Comparison of metabolic gene expression in phenotyped field populations of An. coluzzii  revealed 
lower FCs overall, but notably, increased overexpression of CYP6P3 in survivors of bendiocarb, 
deltamethrin, PBO + deltamethrin and permethrin (FC = 3.91, 95% CI: 3.33-22.16; 2.21, 95% CI: 1.88-
12.53; 2.64, 95% CI: 2.21-13.69; and 2.21, 95% CI: 1.99-20.03, respectively) (Figure 5). 
Discussion 
 
Côte d’Ivoire has hot spots of some of the highest levels of resistance of Anopheles mosquitoes to 
public health insecticides worldwide, with potentially severe implications for sustaining gains in 
malaria control [31]. To safeguard malaria vector control efforts and inform the design of effective 
resistance management strategies, involving tactical deployment of differing IRS and LLIN modalities, 
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there needs to be a clear understanding of contemporary phenotypic and genotypic insecticide 
resistance. 
  
Our study detected intense pyrethroid resistance in south-east, Côte d’Ivoire, as evidenced by high 
proportions of survivors, following exposure to ten times the diagnostic doses of pyrethroids, as well 
as very low levels of knock-down and 24-hour mortality to deltamethrin-only LLINs, equivalent to an 
untreated net. These findings are largely in agreement with historical resistance profiles from this 
region [7,10,11] and indicate that conventional LLINs may no longer be operationally viable in areas 
of high pyrethroid resistance intensity. Previous Phase II studies of pyrethroid-only LLINs in the 
central region of Côte d’Ivoire have demonstrated similarly poor efficacy with highly resistant An. 
gambiae s.l. populations but argued for the retention of some degree of personal protection [15-17]. 
Other observational cohorts have reported higher incidences of malaria among non-net users 
compared to users in areas of moderate to high pyrethroid resistance [17]. The extent of protective 
efficacy afforded by pyrethroid LLINs will likely reflect the strength of local vector resistance and 
levels of both net physical integrity and individual compliance *32,33+; in Côte d’Ivoire, reported LLIN 
usage has been low, requiring additional behavioural interventions [2,34]. Our findings of high 
mosquito mortality following exposure to clothianidin and chlorfenapyr and improved vector 
susceptibility with PBO treatment (on both LLINs and in resistance bioassays), are consistent with 
data from other sentinel sites across Côte d’Ivoire *16,35,36+, and strongly support the deployment 
of vector control interventions incorporating these new active ingredients. 
 Study results indicate that An. coluzzii was the predominant local vector species during the rainy 
season, as observed previously [7], circulating sympatrically with smaller proportions of An. gambiae 
s.s.. These two vector species commonly co-habit but can be genetically distinct in terms of 
resistance mechanisms [37,38] and can also differ in larval ecology, behaviour, migration and 
aestivation [39-41]. In general, resistance mechanisms in An. coluzzii are less well-characterized, 
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compared to An. gambiae s.s., in part because these vectors are morphologically indistinguishable 
and few studies present data disaggregated by PCR-confirmed species. We observed several distinct 
features in our study, principally, evidence for ongoing selection of L1014F kdr and G119S Ace-1 in 
An. coluzzii, which was absent in An. gambiae s.s. and higher proportions of N1575Y in An. gambiae 
s.s.; expression levels of metabolic genes were comparable between species. The lack of association 
between L1014F kdr genotype and mosquito phenotype, coupled with the identification of three 
CYP450 enzymes (CYP6P4, CYP6P3 and CYP6Z1) that were significantly over-expressed in field 
populations, (some of which are known to metabolise pyrethroids and next generation LLIN 
insecticides [42,43]), indicate a key role for metabolic resistance in this An. coluzzii population. One 
notable difference in our dataset, compared to previous work in Agboville [7], was the finding of 
bendiocarb susceptibility. This may be attributable to small-scale spatial and longitudinal 
heterogeneity in resistance, which can be highly dynamic [37,44], and/or phenotypic differences 
between vector species; complicating intervention choice for resistance management.   
  
With the exception of chlorfenapyr, which is known to be a slow-acting insecticide, no delayed 
mortality effects were detected following insecticidal exposure; the format and dose used for 
clothianidin testing (another slow-acting insecticide [45]) was instead intended to measure acute 
toxicity within a 60 minute exposure period. Previous mathematical models using resistant mosquito 
colonies have suggested that sub-lethal insecticide treatment may still reduce vector lifespan and 
inhibit blood-feeding and host-seeking behaviours, thereby interrupting malaria transmission 
[46,47]. Our observations are more compatible with reports from Burkina Faso where different 
exposure regimens of wild, resistant An. gambiae s.l. populations to deltamethrin LLINs did not 
induce any delayed mortality [47]. Further assessment of sublethal effects are warranted across 
additional field populations with differing resistance mechanisms to better understand the impact of 
insecticidal exposure on vectorial capacity of resistant mosquitoes.   
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To date there is a paucity of data regarding the interactions between insecticide resistance and 
Plasmodium development [48]. In this study, An. coluzzii which died following pyrethroid exposure 
were significantly more likely to be infected with malaria. This might be explained by elevated 
metabolic enzymes and/or prior pyrethroid exposure detrimentally affecting parasite development 
[49]; although it is important to note that we did not detect any significant differences between 
gene overexpression in malaria infected vs. non-infected An. coluzzii. Alternatively, our sampled 
population may have been physiologically older, as phenotypic resistance is known to decline with 
age [50]. It is impossible to distinguish between these hypotheses using field-collected vector 
populations; the experimental design used in this study had other biological and technical 
limitations, which have been described in detail previously [23,37]. 
 
Conclusions 
As new combination and bi-treated vector control interventions become available for deployment, 
contemporary resistance information is crucial for the rationale design of management strategies 
and to mitigate further selection for particular resistance mechanisms. The results from this study 
contribute to growing insecticide resistance data for Côte d’Ivoire, demonstrating a loss of 
bioefficacy of pyrethroid LLINs and supporting the use of new active ingredients (clothianidin, 
chlorfenapyr and PBO). Study findings also highlight the need for expanded insecticide resistance 
surveillance, including monitoring of metabolic resistance mechanisms, in conjunction with studies 
to better characterize the impact of sublethal insecticide exposure on vectorial capacity and the 
interaction between insecticide resistance and Plasmodium parasite development.  
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Figure Legends 
 
Figure 1. Bioefficacy of different unwashed LLINs against field-caught An. gambiae s.l. Mean knock-
down and mortality rates with 95% confidence intervals (CI) at 60 minutes and 24 hours, 
respectively, after 3 minutes exposure to PermaNet® 2.0 (deltamethrin only), side panels of 
PermaNet® 3.0 (deltamethrin only), roof panels of PermaNet® 3.0 (PBO + deltamethrin) and an 
untreated control net. Knock-down or mortality in the same time period for each treatment sharing 
a letter do not differ significantly (p>0.05). Green lines at ≥75% knock-down = minimal effectiveness 
at 60 minutes and at ≥ 95% knock-down = optimal effectiveness at 60 minutes. Red lines at ≥50% 
mortality = minimal LLIN effectiveness at 24 hours and ≥80% mortality = optimal LLIN effectiveness 
at 24 hours, as defined by the WHO [21]. 
 
Figure 2. A: Resistance intensity of field-caught An. gambiae s.l. after exposure to one, two, five and 
ten times the diagnostic dose of pyrethroid insecticides.  Mean knock-down/acute toxicity after 30 
minutes exposure with 95% confidence intervals (CI). Knock-down/mortality at the same dose per 
insecticide sharing a letter do not differ significantly (p>0.05). Values of less than 90% mortality 
(lower red line) indicate confirmed resistance at the diagnostic dose (1X) and values of less than 98% 
mortality (upper red line) indicate moderate to high intensity resistance or high intensity resistance 
at 5X and 10X, respectively, as defined by the WHO [24]. B: Restoration of deltamethrin 
susceptibility of field-caught An. gambiae s.l. after pre-exposure to PBO. Mean knock-down/acute 
toxicity after 30 minutes exposure to one or two times the diagnostic dose of deltamethrin with 95% 
confidence intervals (CI). Knock-down/mortality between pyrethroid only and synergist + pyrethroid 
sharing a letter do not differ significantly (p>0.05). Red line at 98% mortality indicates metabolic 
resistance mechanisms partially involved [24]. 
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Figure 3. The longevity of field-caught An. gambiae s.l. after exposure to LLINs in WHO cone assays 
(A) 1X (B), 5X (C) and 10X (D) times the diagnostic dose of pyrethroid insecticides in CDC resistance 
intensity assays. Kaplan Meier survival curves indicate the proportion alive each day post-exposure. 
Immediate mortality following LLIN (60 minutes and 24 hours) or insecticidal exposure (30 or 60 
minutes, insecticide depending) were excluded.  
 
Figure 4. Metabolic gene expression in field An. coluzzii and An. gambiae s.s. populations relative to 
a susceptible colony population. Error bars represent 95% CI; statistically significant differences in 
expression levels relative to the susceptible colony are indicated as *P<0.05, **P<0.01, ***P0.001. 
 
Figure 5. Metabolic gene expression in resistant versus susceptible field An. coluzzii, which either 
died or survived following insecticidal exposure. Error bars represent 95% CI. 
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Table 1. Cox proportional hazard model to describe the impact of LLIN/insecticidal exposure on survival 
of field-caught An. gambiae s.l. 72 hours post exposure. 
Insecticide Exposure N (N Events) HRR 95% CI P-value 
Untreated Netting  Reference - - 
PermaNet® 2.0 (deltamethrin 
only) 
1135 (1047) 1.095 0.968-1.239 0.149 
PermaNet® 3.0 side panels 
(deltamethrin only) 
1157 (1088) 0.9664 0.9092-1.027 0.272 
PermaNet® 3.0 roof panels (PBO 
+ deltamethrin) 
563 (533) 1.007 0.939-1.079 0.85 
Acetone Control  Reference - - 
Alpha-cypermethrin 1X 676 (641) 1.006 0.9696-1.043 0.767 
Deltamethrin 1X 683 (645) 0.9942 0.9539-1.036 0.782 
Permethrin 1X 693 (661) 1.015 0.9698-1.062 0.525 
Clothianidin 1X 698 (581) 1.208 0.9227-1.581 0.169 
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Chlorfenapyr 1X 708 (580) 1.692 1.086-2.637 0.02 
PBO + Deltamethrin 1X 630 (577) 0.9662 0.2411-3.873 0.961 
Alpha-cypermethrin 5X 633 (601) 0.9951 0.9407-1.053 0.863 
Deltamethrin 5X 652 (610) 0.9942 0.9393-1.052 0.842 
Permethrin 5X 636 (583) 0.9931 0.8638-1.142 0.923 
Alpha-cypermethrin 10X 624 (587) 0.9951 0.917-1.08 0.906 
Deltamethrin 10X 623 (588) 0.9943 0.9072-1.09 0.902 
Permethrin 10X 656 (603) 1.026 0.9509-1.107 0.509 
1X Insecticide Dose  Reference - - 
Alpha-cypermethrin 5X 117 (92) 1.016 0.9069-1.138 0.785 
Alpha-cypermethrin 10X 108 (78) 1.007 0.9403-1.078 0.845 
Deltamethrin 5X 143 (105) 1.0 0.9035-1.107 1.0 
Deltamethrin 10X 114 (83) 1.0 0.9363-1.068 1.0 
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Permethrin 5X 137 (94) 1.022 0.8528-1.225 0.812 
Permethrin 10X 157 (114) 0.9952 0.9491-1.044 0.842 
HRR: hazard rate ratio; ratio between the hazard rate in control/reference group and hazard rate for 
each treatment group. 
Significance level defined as α = 0.05. 
Immediate mortality following LLIN (60 minutes and 24 hours) or insecticidal exposure (30 or 60 
minutes, insecticide depending) were excluded. 
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Figure 1 
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Figure 2 
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Figure 3A & B 
 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article/doi/10.1093/infdis/jiaa699/5973957 by guest on 12 N
ovem
ber 2020
Ac
ce
pte
d M
an
us
cri
pt 
 
Figure 3 C & D 
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Figure 4 
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Figure 5 
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